SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001640334-22-000689
Filing Date
2022-03-31
Accepted
2022-03-31 17:19:21
Documents
62
Period of Report
2021-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K bdpt_10k.htm   iXBRL 10-K 895723
2 EX-31.1 bdpt_ex311.htm EX-31.1 9451
3 EX-31.2 bdpt_ex312.htm EX-31.2 8818
4 EX-32.1 bdpt_ex321.htm EX-32.1 4212
5 EX-32.2 bdpt_ex322.htm EX-32.2 4172
11 bdpt_10kimg1.jpg GRAPHIC 4198
  Complete submission text file 0001640334-22-000689.txt   4009646

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA bdpt-20211231.xsd EX-101.SCH 41245
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE bdpt-20211231_lab.xml EX-101.LAB 246453
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE bdpt-20211231_cal.xml EX-101.CAL 37070
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bdpt-20211231_pre.xml EX-101.PRE 207575
10 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE bdpt-20211231_def.xml EX-101.DEF 119740
56 EXTRACTED XBRL INSTANCE DOCUMENT bdpt_10k_htm.xml XML 550729
Mailing Address 1015 S CIMARRON RD LAS VEGAS NV 89145
Business Address 1015 S CIMARRON RD LAS VEGAS NV 89145 (702) 560-1632
BIOADAPTIVES, INC. (Filer) CIK: 0001575142 (see all company filings)

IRS No.: 462592228 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-54949 | Film No.: 22794316
SIC: 2834 Pharmaceutical Preparations